Three-dimensional (3D) printing, also referred to as additive manufacturing, is driving major innovations in the area of engineering, medicine, manufacturing and art. Advances in this technology have enabled the fabrication of functional tissue substitutes using biocompatible materials, cells and supporting components.

3D bioprinting technology promises to bridge the gap between laboratory-cultured tissue constructs and native tissues and organs. Cellink’s state-of-the-art extrusion and light-based bioprinters help unlock greater insights by building more complex and physiologically relevant tissue models, enabling advances in critical research areas including personalised medicine, drug discovery, regenerative medicine and cosmetics to name a few. From printing artificial corneas for curing corneal blindness to developing wound-healing patches for delivering antibiotics, Cellink’s technology significantly impacts the future of healthcare.

By combining the field of materials science, biomechanics, sensing and cells, our advanced bioprinters have helped in developing biohybrid soft robotics and biosensors. 4D bioprinting, an advance of 3D bioprinting technology, utilising the dimension of time and shape on printed structures, is the most recent medical technology made possible with Cellink’s technology, transforming the artificial organs and prosthetic industry. In this presentation, I will bring forward the applications of 3D bioprinting technology with recent successes and future translations in various domains.

Register Now

Venue: University of Southern Queensland, Springfield Campus, School of Engineering, Building B, Level 4, Room B456, 37 Sinnathamby Blvd, Springfield Central, QLD 4300

_{* Registration is essential so we can organise catering}

Program

1.00pm – 3D Bioprinting Seminar
1.45pm – Tea break
2.00 pm – Bioprinter demonstrations

Presenters

BIO X

Extrusion-based bioprinter with intelligent printheads

BIONOVA X

High throughput DLP-based bioprinter